For those who missed the first news about Fullerene C60's apparent beneficial properties in it's non-toxic (non manipulated) form, this description of observations seems fair;
Researchers led by Fathi Moussa of the University of South Paris in France periodically injected rats with a solution of buckyballs dissolved in olive oil. They say that the rats lived an average of 42 months. Control rats injected with water had an average lifespan of just 22 months, and rats injected with olive oil alone lived to 26 months on average.
Just to undo the media trick embedded in the text...
Control life span 22 months.
C60/Olive oil increased lifespan: 52%
Olive oil alone increased lifespan: 5%
Dissenters present - first via Huffington Post, then retold in the OP source - a series of disingenuous comparisons, wherein they didn't compare apples to apples. Note the above extracted text speaks of months... the dissenter speak in "percentages" which makes comparison less clear.
In order to contrast the apparent indications one might infer from the French Scientists work, they cite that:
Calorie restriction extends the life of nematodes by as much as 40 per cent.
A - no mention of how long that is
B - no mention of the fact that a nematode is an organism that survives if you cut it in half... in other words multiple redundant bodily structures
C -A complete disregard for the fact that a nematode is not a mammal, nor is mammal like in most ways.
The anti-organ-rejection drug rapamycin makes mice live 10 per cent longer.
A - here are some "side effects" of rapamycin (which is a fungal-derived synthetic): dramatic depletion of blood platelets, and abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. (as well as fast heart rate; pain when you breathe, feeling short of breath; chest pain, feeling weak or tired; coughing up blood or mucus; feeling like you might pass out; pale skin, easy bruising or bleeding, weakness; fever, chills, body...)
B - 10% is a far cry from 50%
The authors mention other life-extension possibilities but fail to even offer any metrics to compare.
I had mentioned in the earlier thread on C60, that this kind of represents a threat to certain 'commercial' elements of the well-entrenched transnational health care businesses ...
Now I am certain of it.
I hope this doesn't get swept away by the media efforts to 'form opinions' for us... but with few places like ATS to discuss them... I am concerned.....
Apparently, the establishment will contrive all manner of verbiage to ensure we don't take this seriously... which - I might add - is why I am inclined to do just that.
www.newscientis t.com
(visit the link for the full news article)
edit on 26-4-2012 by Maxmars because: (no reason given)
edit on 26-4-2012 by Maxmars
because: (no reason given)


)
